Biochemistry, Genetics and Molecular Biology
Lipid
100%
Prevalence
88%
Lipid Profile
88%
Body Mass
62%
Apolipoprotein
59%
Cholesterol Blood Level
48%
Genotyping
44%
Case-Control Study
44%
Escherichia coli
44%
Haplotype
44%
Genetic Determinism
44%
Diastolic Blood Pressure
44%
Hypovitaminosis D
44%
Blood Pressure
44%
Systolic Blood Pressure
44%
Antibiotic Resistance
44%
Human Leukocyte Antigen
44%
Complement Receptor 1
44%
Genetic Polymorphism
44%
Beta-Lactamase
44%
Genomics
44%
Hip Circumference
44%
High-Density Lipoprotein
37%
Apolipoprotein B
33%
Genetic Risk
33%
Serum Lipids
33%
Blood Lipids
33%
Waist Circumference
29%
Lipid Level
22%
Plasmid
14%
Body Water
14%
Mobile Genetic Elements
14%
Whole Genome Sequencing
14%
Replicon
14%
Ampicillin
14%
Illumina MiSeq
14%
Sulfamethoxazole
14%
Trimethoprim
14%
Triglyceride
14%
Triacylglycerol Level
14%
Body Weight Loss
14%
Allele
14%
HDL-Cholesterol
11%
Cohort Study
11%
Comorbidity
11%
Blood Group Antigen
8%
Sample Size
8%
Restriction Fragment Length Polymorphism
8%
Blood Group
8%
Polymerase Chain Reaction
8%
Medicine and Dentistry
Multiple Sclerosis
80%
Disease Course
51%
Obesity
44%
Escherichia coli
44%
Public Health
44%
Laceration
44%
Injury
44%
Study Subject
44%
Comorbidity
44%
Antibiotic Resistance
26%
Hip
26%
Beta-Lactamase
26%
Health Outcomes
25%
Dermabrasion
22%
Physical Examination
22%
Blood Pressure
22%
First Aid
22%
Diastolic Blood Pressure
22%
Systolic Blood Pressure
22%
Thermal Burn
22%
Prevalence
22%
Disinfectant Agent
22%
Body Mass Index
21%
Triacylglycerol
21%
Antibiotic Resistant Bacteria
17%
High-Density Lipoprotein
12%
Cardiovascular Disease
11%
Expanded Disability Status Scale
8%
Apolipoprotein
8%
Linear Regression Analysis
8%
Central Nervous System
8%
Survival Analysis
8%
Demyelination
8%
Replicon
8%
Illumina MiSeq
8%
Whole Genome Sequencing
8%
Health Hazard
8%
Trimethoprim/Sulfamethoxazole
8%
Meropenem
8%
Penicillinase
8%
Carbapenemase
8%
Body Weight Loss
8%
Azithromycin
8%
Plasmid
8%
Ampicillin
8%
Surface Water
8%
Statin
7%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
66%
Multiple Sclerosis
44%
Randomized Controlled Trial
44%
Cholecalciferol
44%
Poliomyelitis Virus
44%
Enterovirus
44%
Musculoskeletal Disease
44%
Injury
44%
Infection
44%
Asthma
44%
Laceration
44%
Burn
44%
Vitamin D
44%
Comorbidity
44%
Small Airway Disease
22%
Skin Abrasion
22%
Exposure Assessment
22%
Cohort Study
22%
Chronic Obstructive Lung Disease
22%
Random Effects Model
22%
Occupational Exposure
22%
Cardiovascular Disease
11%
Acute Brain Disease
8%
Case Fatality Rate
8%
Arbovirus
8%
Disease Course
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Placebo
5%
Adverse Event
5%